Please login to the form below

Not currently logged in
Email:
Password:

early asset development

This page shows the latest early asset development news and features for those working in and with pharma, biotech and healthcare.

Redefining launch excellence in 2017

Redefining launch excellence in 2017

Now, more so than ever, launch preparation and commercial involvement should begin as early as possible in the asset’s development. ... It is crucial that these teams connect as early as possible, because whether it is intentional or not, the

Latest news

  • Cello Health expands with Defined Health acquisition Cello Health expands with Defined Health acquisition

    Defined Health will work closely with its new parent company in early asset development and commercialisation, with a particular focus on defining value for early-stage compounds. ... offer our clients through the full span of the development process

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Assessing early market opportunity Assessing early market opportunity

    To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process. ... On the 19. th. April Cello Health, in association with PMGroup, will host a free webinar which will discuss the background

  • Managing value: Why early asset development and commercialisation are important Managing value: Why early asset development and commercialisation are important

    Realising the full value of your asset - clinically and commercially - means thinking beyond the pure scientific value, even at the very early stages of development. ... Unsurprisingly, slightly more than half (approximately 8, 000) of those in

  • The value of early asset development and commercialisation The value of early asset development and commercialisation

    On July 13 Cello Health, in association with PMGroup, will host a free webinar on the value of early asset development and commercialisation. ... It will follow the asset development journey, defining value from both a financial and clinical perspective,

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics